Takeda Pharmaceutical Company Limited announced that Miki Tsusaka was newly elected as director at its Ordinary General Meeting of Shareholders held on June 28, 2023.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
4,133 JPY | -0.77% | -1.71% | +1.95% |
May. 16 | Takeda Canada Completes LOI Stage for Post-Transplant Cytomegalovirus Treatment | MT |
May. 15 | Takeda Pharmaceutical's Dengue Vaccine Granted WHO Prequalification | MT |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+1.95% | 41.87B | |
+38.68% | 705B | |
+32.03% | 583B | |
-3.15% | 364B | |
+21.26% | 332B | |
+6.00% | 291B | |
+15.64% | 238B | |
-3.64% | 210B | |
+10.49% | 209B | |
+9.12% | 169B |
- Stock Market
- Equities
- 4502 Stock
- News Takeda Pharmaceutical Company Limited
- Takeda Pharmaceutical Company Limited Announces Board Changes